Vaccination I
Aims of Vaccination
Block transmission and preventing symptoms of disease
Protect individual against symptoms or pathology
Requirements
Effective, safe, stable and cheap
Effective:
Humoral and cell mediated response required for resistance to intra and inter
cellular pathogens
Don’t want activation of cytotoxic T cells
Duration:
Short term not adequate
Need induction of immunological memory
Diseases with longer incubation periods is better as immune system has time to
respond
Immunological memory can be boosted if outbreaks of the disease takes place
Live vaccines induce a stronger longer lasting immunity
Safety:
May cause disease
Cant administer to immunosuppressed patients
May be contaminated
Stability:
Need shelf-life
Cold storage between factory and clinic
Cost:
Cheap enough for developing countries
Types of Vaccines
Pathogens with reduced virulence artificially (attenuated)
Pathogens with reduced virulence in humans naturally
Killed organisms
Cellular fragments of pathogens
Passive Immunisation
Injection of purified antibodies or antibody containing serum to provide rapid,
temporary protection or treatment
Natural passive immunity – maternal IGs through breast milk
Used for:
Prevent disease after exposure
Reduce symptoms of on-going disease
Protect immune deficient patients
Block bacterial toxins and prevent disease they may cause
Examples:
Prophylaxis – Hepatitis A, Diphtheria and Tetanus
Post exposure – Rabies, Hepatitis B and Measles
Prophylaxis in immune deficient patients – Varicella Zoster
Active Immunisation
, Administration of live vaccines or inactivated pathogens
Attenuated vaccines:
Selection of mutant pathogens (inactive)
Attenuated by passage through cell cultures or chemically
Oral Polio vaccine:
Passed though monkey kidneys or human embryo fibroblasts
Virulence checked by signs of nephrotoxicity in monkeys
Inactivated vaccines:
Killed or inactivated pathogens by heat or chemicals
Used when live vaccines aren’t possible or appropriate for patient
Sometimes attenuation cant be achieved as the pathogen reactivates
Advantages – not infectious and relatively safe
Disadvantages – lower immunogenicity so several doses needed for lasting
immunity, contaminated by toxins, allergic reaction or autoimmunity
Cellular fragments:
Protective immunity against a specific part of a pathogen – polysaccharide
capsule of Pneumococci or coating of HBV
Can remove DNA/RNA from pathogen
Bacterial toxins can be inactivated chemically – toxoids (Diphtheria and
Tetanus)
DNA vaccines:
DNA and promoter
Not used in humans yet
Possible oncogene insertion
Living vs Non-Living Vaccination
Vaccination II
Aims of Vaccination
Block transmission and preventing symptoms of disease
Protect individual against symptoms or pathology
Requirements
Effective, safe, stable and cheap
Effective:
Humoral and cell mediated response required for resistance to intra and inter
cellular pathogens
Don’t want activation of cytotoxic T cells
Duration:
Short term not adequate
Need induction of immunological memory
Diseases with longer incubation periods is better as immune system has time to
respond
Immunological memory can be boosted if outbreaks of the disease takes place
Live vaccines induce a stronger longer lasting immunity
Safety:
May cause disease
Cant administer to immunosuppressed patients
May be contaminated
Stability:
Need shelf-life
Cold storage between factory and clinic
Cost:
Cheap enough for developing countries
Types of Vaccines
Pathogens with reduced virulence artificially (attenuated)
Pathogens with reduced virulence in humans naturally
Killed organisms
Cellular fragments of pathogens
Passive Immunisation
Injection of purified antibodies or antibody containing serum to provide rapid,
temporary protection or treatment
Natural passive immunity – maternal IGs through breast milk
Used for:
Prevent disease after exposure
Reduce symptoms of on-going disease
Protect immune deficient patients
Block bacterial toxins and prevent disease they may cause
Examples:
Prophylaxis – Hepatitis A, Diphtheria and Tetanus
Post exposure – Rabies, Hepatitis B and Measles
Prophylaxis in immune deficient patients – Varicella Zoster
Active Immunisation
, Administration of live vaccines or inactivated pathogens
Attenuated vaccines:
Selection of mutant pathogens (inactive)
Attenuated by passage through cell cultures or chemically
Oral Polio vaccine:
Passed though monkey kidneys or human embryo fibroblasts
Virulence checked by signs of nephrotoxicity in monkeys
Inactivated vaccines:
Killed or inactivated pathogens by heat or chemicals
Used when live vaccines aren’t possible or appropriate for patient
Sometimes attenuation cant be achieved as the pathogen reactivates
Advantages – not infectious and relatively safe
Disadvantages – lower immunogenicity so several doses needed for lasting
immunity, contaminated by toxins, allergic reaction or autoimmunity
Cellular fragments:
Protective immunity against a specific part of a pathogen – polysaccharide
capsule of Pneumococci or coating of HBV
Can remove DNA/RNA from pathogen
Bacterial toxins can be inactivated chemically – toxoids (Diphtheria and
Tetanus)
DNA vaccines:
DNA and promoter
Not used in humans yet
Possible oncogene insertion
Living vs Non-Living Vaccination
Vaccination II